Robert Ang

Robert Ang

Former President and Chief Executive OfficeratVor Biopharma· In proxies 2022–2025

Pay in FY2025Vor Biopharma stock -41.1% the same year

Robert Ang was paid $3.4M in FY2025 (Dec). Vor Biopharma stock fell 41.1% that year.

Pay$100 in the stock at the end of FY21 → $34
Pay is from the Summary Compensation Table of each Vor Biopharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Vor BiopharmaPublic company · 4 yr
    • Former President and Chief Executive Officer2022 – Present · 4 yrStock in role -92%
  2. Alliance for Regenerative MedicinePublic company · 4 yr
    • Director2022 – Present · 4 yrNo stock prices for these years
  3. Enara Bio LimitedPublic company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?